The short version
Only one company currently supplies this market — there is no backup if it stumbles. It is in shortage right now.
Market view
sodium acetate anhydrous · Solution, Concentrate
2 marketed package NDCs · 1 active manufacturer
What changed in the last 90 days
Every detected change for sodium acetate anhydrous, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.
- Sodium acetate anhydrousJul 22, 2026New shortageby this manufacturerSomerset Therapeutics, LLC's Sodium acetate anhydrous (Injection, 164 mg/1 mL) is newly in shortage1 company markets sodium acetate anhydrous · 5 have products in shortage
- Sodium acetate anhydrousJul 22, 2026New shortageby this manufacturerSomerset Therapeutics, LLC's Sodium acetate anhydrous (Injection, 164 mg/1 mL) is newly in shortage1 company markets sodium acetate anhydrous · 5 have products in shortage
Common questions
- Is Sodium acetate anhydrous in shortage right now?
- Yes. FDA currently lists Sodium acetate anhydrous in shortage. This page is rebuilt every morning from FDA's shortage database.
- Who makes Sodium acetate anhydrous?
- 1 company has marketed Sodium acetate anhydrous in the last 30 days, according to the FDA NDC Directory. That is a thin market — if one stops making it, supply is at risk quickly. Every manufacturer and package is listed on this page.
Shortage reports for this molecule
- In shortage now — Sodium Acetate, Injection, 164 mg/1 mL (NDC 70069-047-25)Feb 3, 2016
- In shortage now — Sodium Acetate, Injection, 164 mg/1 mL (NDC 70069-048-20)Feb 3, 2016
All marketed products
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.